Skip to main
AVTR

Avantor Inc. (AVTR) Stock Forecast & Price Target

Avantor Inc. (AVTR) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 0%
Buy 31%
Hold 62%
Sell 8%
Strong Sell 0%

Bulls say

Avantor Inc. is positioned positively due to significant market share gains of $100 million resulting from successful contract renegotiations, which are expected to enhance volume and lead to better fixed cost absorption. The company operates in a robust healthcare sector and anticipates margin expansion that aligns more closely with industry peers, suggesting potential for multiple expansion over time. Furthermore, ongoing demand for Avantor's core mAb platform and projected cost savings exceeding $250 million by 2025 underscore a solid foundation for future growth.

Bears say

Avantor Inc. has revised its FY25 organic revenue growth outlook downward to between -2% and 0%, reflecting persistent headwinds in the bioprocessing sector and a revenue decline in 2Q. The company anticipates a further contraction in organic growth for 3Q25, with projections of -4% to -2%, amidst challenges faced by key bioprocess customers and inventory adjustments in the silicone materials segment. Additionally, the adjusted EBITDA margins missed consensus expectations, and the overall financial performance indicates a sustained vulnerability, which could hinder any potential recovery in the near term.

Avantor Inc. (AVTR) has been analyzed by 13 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 31% recommend Buy, 62% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avantor Inc. (AVTR) Forecast

Analysts have given Avantor Inc. (AVTR) a Hold based on their latest research and market trends.

According to 13 analysts, Avantor Inc. (AVTR) has a Hold consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avantor Inc. (AVTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.